DNTH
Price
$106.20
Change
+$2.92 (+2.83%)
Updated
Sep 11 closing price
Capitalization
5.94B
54 days until earnings call
Intraday BUY SELL Signals
XENE
Price
$58.65
Change
-$0.15 (-0.26%)
Updated
Sep 11 closing price
Capitalization
5.68B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DNTH vs XENE

DNTH vs XENE Comparison Chart in %
View a ticker or compare two or three
VS
DNTH vs. XENE commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and XENE is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($5.94B) and XENE($5.68B) have the same market capitalization . DNTH YTD gains are higher at: 157.704 vs. XENE (30.857). DNTH has higher annual earnings (EBITDA): -217.46M vs. XENE (-439.19M). XENE (931M) and DNTH (887M) have equal amount of cash in the bank . DNTH has less debt than XENE: DNTH (1.29M) vs XENE (6.42M). DNTH has higher revenues than XENE: DNTH (1.9M) vs XENE (0).
DNTHXENEDNTH / XENE
Capitalization5.94B5.68B105%
EBITDA-217.46M-439.19M50%
Gain YTD157.70430.857511%
P/E Ratio3.24N/A-
Revenue1.9M0-
Total Cash887M931M95%
Total Debt1.29M6.42M20%
FUNDAMENTALS RATINGS
DNTH vs XENE: Fundamental Ratings
DNTH
XENE
OUTLOOK RATING
1..100
7284
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
225
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
3644
P/E GROWTH RATING
1..100
555
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XENE's Valuation (79) in the Biotechnology industry is in the same range as DNTH (83) in the null industry. This means that XENE’s stock grew similarly to DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (2) in the null industry is in the same range as XENE (25) in the Biotechnology industry. This means that DNTH’s stock grew similarly to XENE’s over the last 12 months.

DNTH's SMR Rating (96) in the null industry is in the same range as XENE (97) in the Biotechnology industry. This means that DNTH’s stock grew similarly to XENE’s over the last 12 months.

DNTH's Price Growth Rating (36) in the null industry is in the same range as XENE (44) in the Biotechnology industry. This means that DNTH’s stock grew similarly to XENE’s over the last 12 months.

XENE's P/E Growth Rating (5) in the Biotechnology industry is somewhat better than the same rating for DNTH (55) in the null industry. This means that XENE’s stock grew somewhat faster than DNTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHXENE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 10 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 2 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
70%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (DNTH: $106.20 vs. XENE: $58.65)
Brand notoriety: DNTH and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 97% vs. XENE: 49%
Market capitalization -- DNTH: $5.94B vs. XENE: $5.68B
DNTH [@Biotechnology] is valued at $5.94B. XENE’s [@Biotechnology] market capitalization is $5.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 1 FA rating(s) are green while XENE’s FA Score has 2 green FA rating(s).

  • DNTH’s FA Score: 1 green, 4 red.
  • XENE’s FA Score: 2 green, 3 red.
According to our system of comparison, XENE is a better buy in the long-term than DNTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 5 TA indicator(s) are bullish while XENE’s TA Score has 3 bullish TA indicator(s).

  • DNTH’s TA Score: 5 bullish, 3 bearish.
  • XENE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than XENE.

Price Growth

DNTH (@Biotechnology) experienced а -1.76% price change this week, while XENE (@Biotechnology) price change was -1.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 05, 2026.

XENE is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DNTH
Daily Signal:
Gain/Loss:
XENE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MIDU65.331.42
+2.22%
Direxion Daily Mid Cap Bull 3X ETF
SMHX56.691.10
+1.97%
VanEck Fabless Semiconductor ETF
SCHX30.110.25
+0.84%
Schwab US Large-Cap ETF™
JHMD45.850.34
+0.75%
JHancock Multifactor Developed Intl ETF
REK16.02-0.15
-0.93%
ProShares Short Real Estate

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with XENE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+2.83%
XENE - DNTH
46%
Loosely correlated
-0.26%
EDIT - DNTH
42%
Loosely correlated
+1.89%
REPL - DNTH
41%
Loosely correlated
-2.42%
CLDX - DNTH
40%
Loosely correlated
-3.15%
IMTX - DNTH
40%
Loosely correlated
+0.46%
More

XENE and

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with RLMD. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then RLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
-0.26%
RLMD - XENE
55%
Loosely correlated
+11.06%
ANTX - XENE
46%
Loosely correlated
-4.92%
MLTX - XENE
44%
Loosely correlated
-5.08%
DNTH - XENE
43%
Loosely correlated
+2.83%
REPL - XENE
42%
Loosely correlated
-2.42%
More